Drug Design and Delivery for Intracellular Bacteria: Emerging Paradigms
Drug Development Research · 2025-12 · 86 (8)
DOI: 10.1002/ddr.70198 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 19.11.2025. Verfasst von Babatunde Ibrahim Olowu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Multidisciplinary Program in Infectious Diseases, Department of Veterinary Microbiology, College of Veterinary Medicine, Washington State University,…. Hauptthemen laut MEDLINE: Drug Design, Anti-Bacterial Agents, Drug Delivery Systems, Bacteria. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Intracellular bacteria exploit host cell niches, such as lysosomes, phagosomes, cytosol, entire cells, and even erythrocytes, to evade immune clearance and escape conventional antibiotics. These environments pose numerous therapeutic challenges, including crossing host cell membranes, navigating endosomal trafficking, tolerating acidic and redox conditions, bypassing efflux mechanisms, and countering phenotypic tolerance. Although recent advancements in nanotechnology—such as carriers, prodrugs, and host‐directed therapies—offer promising solutions, current strategies remain narrowly focused on “getting the drug inside the cell”, leaving therapeutic agents vulnerable to off‐site targeting, degradation, and functional failure. This review introduces a next‐generation approach for intracellular antibacterial therapy, incorporating subcellular targeting, dual‐function delivery systems, innovative biomimetic carriers, precise intracellular pharmacokinetics/pharmacodynamics (PK/PD) assessment, and artificial intelligence‐assisted drug design. Highlighting frameworks for multimodal regimens targeting intracellular bacteria, we advocate a transition from solely facilitating cellular entry to achieving precise spatiotemporal regulation of drug activity within infected host cells. This paradigm informs the development of therapeutics designed to persist within the intracellular bacterial niche, minimizing relapse and reducing the emergence of antimicrobial resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Multidisciplinary Program in Infectious Diseases, Department of Veterinary Microbiology, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA.
- Program in Global Health and Infectious Diseases, Edinburgh Medical School, College of Veterinary Medicine, The University of Edinburgh, Edinburgh, UK.
- School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.
- Department of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
- Department of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Abuja, Abuja, Nigeria.
- Department of Pharmacy, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.
ORCID-Profile: Babatunde Ibrahim Olowu
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Olowu, B. I., Zakariya, M. E., Abdulkareem, A. A., Okewale, O. T., Idris, M. H., & Olayiwola, H. O. (2025). Drug Design and Delivery for Intracellular Bacteria: Emerging Paradigms. Drug Development Research, 86(8). https://doi.org/10.1002/ddr.70198
Vancouver
Olowu BI, Zakariya ME, Abdulkareem AA, Okewale OT, Idris MH, Olayiwola HO. Drug Design and Delivery for Intracellular Bacteria: Emerging Paradigms. Drug Development Research. 2025;86(8). doi:10.1002/ddr.70198
BibTeX
@article{Olowu2025,
author = {Olowu, Babatunde Ibrahim and Zakariya, Maryam Ebunoluwa and Abdulkareem, Abdulmuheez Abiola and Okewale, Olalekan Toheeb and Idris, Muhammad Halima and Olayiwola, Halimah Oluwayemisi},
title = {Drug Design and Delivery for Intracellular Bacteria: Emerging Paradigms},
journal = {Drug Development Research},
year = {2025},
volume = {86},
number = {8},
doi = {10.1002/ddr.70198}
}
EUVIMED